期刊文献+

硼替佐米对人绒毛膜癌细胞增殖及凋亡的影响

Effect of Proteasome Inhibitor Bortezomib on Proliferation,Apoptosis of Human Choriocarcinoma JEG3 Cells
下载PDF
导出
摘要 目的:探讨蛋白酶体抑制剂硼替佐米对人绒毛膜癌细胞株JEG-3细胞增殖、凋亡及核因子κB(NF-κB)表达的影响。方法:设空白对照组,以不同浓度(0.1~200nmol/L)硼替佐米作用于JEG-3细胞,采用CCK-8法检测细胞增殖抑制率,以荧光显微镜检、流式细胞仪检测细胞凋亡,免疫荧光法检测细胞NF-κB的表达。结果:不同浓度的硼替佐米作用于人绒毛膜癌JEG-3细胞48小时,细胞增殖抑制率随着药物浓度增加逐渐增强(P<0.05)。以10nmol/L硼替佐米作用于JEG-3细胞24小时、48小时、72小时,随着作用时间延长细胞增殖抑制率逐渐增强(P<0.01)。与对照组比较,10nmol/L硼替佐米作用于JEG-3细胞48小时,荧光显微镜下见细胞核固缩、核碎裂及凋亡小体,AnnexinV-FITC/PI双标法显示细胞凋亡率增高(P<0.01)。免疫荧光结果显示硼替佐米组凋亡细胞中NF-κB表达增强。结论:在一定浓度、时间内,硼替佐米呈浓度、时间依赖性抑制人绒毛膜癌JEG-3细胞的增殖,诱导其凋亡,且细胞凋亡可能与NF-κB表达增强有关。 Objective :To investigate the effect of proteasome inhibitor bortezomib on proliferation,apopto- sis and the expression of NF-KB of human choriocarcinoma JEG-3 cells. Methods:JEG-3 cells were treated with bortezomib at different concentrations(0. 1 ~200 nmol/L). Cell proliferation was analyzed by CCK-8 assay,cell apoptosis by flow cytometry and fluorescence microscope, NF-KB protein expression by immunofluorescence, blank control was set. Results:JEG-3 cells were treated with bortezomib at different concentrations for 48 h respectively,the cell proliferation inhibition rate gradually increased with the increase of drug concentration( P 〈 0.05). JEG-3 cells was treated with bortezomib(10 nmol/L) for 24 h,48h and 72 h,cell prolifera tion inhibition rate gradually increased with the prolonging of drug action time (P 〈0. 01 ). Compared to the control group,JEG-3 cells treated with 10 nmol/L bortezomib for 48 h showed nuclear condensation, nuclear fragmentation,apoptotic body formation and increase of the apoptotic cells rate( P 〈0. 01 ). The expression of N F-KB in apoptotic cells after bortezomib treatment was significantly increased. Conclusions: Bortezomib can inhibit the proliferation of JEG-3 cells,and induce apoptosis concentration and time dependently in a certain scope of concentration and reacting time,which maybe related to the increasing the NF-KB expression.
出处 《实用妇产科杂志》 CAS CSCD 北大核心 2013年第6期433-436,共4页 Journal of Practical Obstetrics and Gynecology
关键词 蛋白酶体抑制剂 硼替佐米 绒毛膜癌 凋亡 Proteasome inhibitor Bortezomib Choriocarcinoma Apoptosis
  • 相关文献

参考文献9

  • 1Adams J. The proteasome:a suilable antineoplastic target [ J ]. Nat Rev Cancer,2004,4 (5) :349 - 360. 被引量:1
  • 2Lenz HJ. Clinical update: proteasome inhibitors in solid tumors [ J ]. Cancer Treat Rev,2003,29( 1 ) :41 -48. 被引量:1
  • 3Driscoll J J, Dechowdhury R. Therapeutically targeting the SUMO yla- tion,ubiquitination and proteasome pathways as a novel anticancer strategy [ J ]. Target Oneol, 2010,5 (4) : 281 - 289. 被引量:1
  • 4Dreicer R,Petrylak D,Agus D,et al. Phase Ⅰ / Ⅱ study of bortezumib plus docetaxel in patients with advanced androgen-indepentent pros- rate cancer[ J]. Clin Cancer Res,2007,13 (4) :1208 -1215. 被引量:1
  • 5马宁,刘子玲,赵殿凤,张永峰,屈蓓蓓,韩庆坤.硼替佐米对卵巢癌SKOV-3/DDP细胞增殖和耐药逆转的影响[J].中国医院药学杂志,2010,30(1):13-16. 被引量:5
  • 6Carol A. A phase I trial of the novel proteasome inhibitor PS341 in ad- vanced solid tumor malignancies [ J ]. Clin Cancer Res,2002,8 ( 14 ) : 2505 - 2511. 被引量:1
  • 7Ka BS, Chang TC,Chen CH, et al. Bortezomib suppresses focal adhe- sion kinase expression via interrupting nuclear factor-kappa B [ J ]. Life Sci,2010,86(5-6) :199 -206. 被引量:1
  • 8Lenz HJ. Clinical update : prnteasome inhibitors in solid tumors[J]. Cancer Treat Rev,2003,29( 1 ) :41 -48. 被引量:1
  • 9Dolcet X, Llobet D, Encinas M, el al. Proteasome inhibitors induce death but activate NF-κB on endometrial carcinoma cell lines and pri- mary culture explants [ J ]. J Biol Chem, 2006, 281 ( 31 ) : 22118 -22130. 被引量:1

二级参考文献9

  • 1李宏建,李贵海,孙付军,尹格平.苦参碱对肿瘤细胞获得性多药耐药的逆转作用[J].中国医院药学杂志,2005,25(5):389-391. 被引量:13
  • 2Lenz H. Clinical update: proteasome inhibitors in solid tumors [J]. Cancer Treat. Rev,2003,29(Suppl 1 ) :41-48. 被引量:1
  • 3Groll M, Berkers CR, Ploegh HI., et al. Crystal structure of the boronic acid-based proteasome inhibitor bortezomib in complex with the yeast 20S proteasome[J]. Structure, 2006 , 14 (3) :451-456. 被引量:1
  • 4Julian A. Development of the Proteasome Inhibitor PS-341[J]. The Oncologist, 2002,7:9-16. 被引量:1
  • 5LeBlanc R, Catley I.P, Hideshima T, etal. Proteasome inhibitor PS341 inhibits human myeloma cell growth in vivo and prolongs survival in a murine model[J]. Cancer Res, 2002, 62 (17) : 4996-5000. 被引量:1
  • 6Mitsiades N, Mitsiades CS, Richardson PG, et al. The proteasome in-hibitor PS2341 potentiates sensitivity of multiple myeloma cells to conventional chemotherapeutic agents: therapeutic applications[J]. Blood, 2003,101 (6) :2377-2380. 被引量:1
  • 7Cusack JC,Rong L, Houston M, et al. Enhanced chemosensitivity to CPT-11 with proteasome inhibitor P8-341: implications for systemic nuclear facto-kB inhibition[J]. Cancer Res, 2001,61 :3535- 3540. 被引量:1
  • 8Teicher BA,Ara G, Herbst R, et al. The proteasome inhibitor PS-341 in cancer therapy[J]. Clin Cancer Res, 1999,5 : 2638- 2645. 被引量:1
  • 9Li QQ, Yunmbam MK,Zhong X, et al. Laetacystin enhances cisplatin sensitivity in resistant human ovarian cancer cell lines via inhibition of DNA repair and ER-CC-1 expression[J]. Cell Mol Biol (Noisy le-grand), 2001,47:61-72. 被引量:1

共引文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部